Mouse intestinal goblet cells expressing SV40 T antigen directed by the MUC2 mucin gene promoter undergo apoptosis upon migration to the villi

Cancer Research

Volumn 61, Issue 8, 2001, Pages 3472-3479

  Gum, James R ^a,b   Hicks, James W ^a   Gillespie, Anne Marie ^b   Rius, Jose L ^a   Treseler, Patrick A ^b   Kogan, Scott C ^b   Carlson, Elaine J ^b   Epstein, Charles J ^b   Kim, Young S ^a,b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; MUCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; FEMALE; GOBLET CELL; INTESTINE VILLUS; MALE; MITOSIS; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; STEM CELL;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; APOPTOSIS; CELL MOVEMENT; FEMALE; GOBLET CELLS; INTESTINE, SMALL; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICROVILLI; MUCINS; ONCOGENES; PROMOTER REGIONS (GENETICS); S PHASE;

EID: 0035870260     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Genetic alterations during colorectal-tumor development
2. Colorectal cancer: Molecules and populations
3. Mucinous carcinoma of the colon and rectum
4. Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary
5. Low frequency of p53 gene mutation and protein expression in mucinous colorectal carcinomas
6. Microsatellite instability in sporadic mucinous colorectal carcinomas: Relationship to clinico-pathological variables
7. Clinicopathological and genetic characteristics of mucinous carcinomas in the colorectum
8. Mouse models for colorectal cancer
9. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse
10. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene
11. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors
12. Molecular cloning of human intestinal mucin (MUC2) cDNA: Identification of the amino terminus and overall sequence similarity to pre-pro-von Willebrand factor
13. Organization and regulatory aspects of the human intestinal mucin gene (MUC2) locus
14. Identification and characterization of the MUC2 (human intestinal mucin) gene 5′-flanking region. Promoter activity in cultured cells
15. Goblet cell-specific expression mediated by the MUC2 mucin gene promoter in the intestine of transgenic mice
16. Control of the cell cycle and apoptosis
17. 1 events and regulation of cell proliferation
18. The mouse intestinal fatty acid binding protein gene: Nucleotide sequence, pattern of developmental and regional expression, and proposed structure of its protein product
19. Analysis of dipeptidyl peptidase IV gene regulation in transgenic mice: DNA elements sufficient for promoter activity in the kidney, but not the intestine, reside on the proximal portion of the gene 5′-flanking region
20. Expression of SV-40 T antigen in the small intestinal epithelium of transgenic mice results in proliferative changes in the crypt and reentry of villus-associated enterocytes into the cell cycle but has no apparent effect on cellular differentiation programs and does not cause neoplastic transformation
21. Regulation of cell number in the mammalian gastrointestinal tract: The importance of apoptosis
22. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
23. Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis
24. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: Relation to bcl-2 expression, hormone receptors, and lymph node metastases
25. Neoplastic lesions of the hematopoietic system
26. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian theory of the origin of the four epithelial cell types
27. Living and commuting in intestinal crypts
28. Use of normal and transgenic mice to examine the relationship between terminal differentiation of intestinal epithelial cells and accumulation of their cell cycle regulators
29. Bi-transgenic mice reveal that K-rasVal12 augments a p53-independent apoptosis when small intestinal villus enterocytes reenter the cell cycle
30. Human mucin genes MUC2, MUC3, MUC4, MUC5AC, MUC5B, and MUC6 express stable and extremely large mRNAs and exhibit a variable length polymorphism. An improved method to analyze large mRNAs
31. Studies of intestinal stem cells using normal, chimeric, and transgenic mice
32. Intestinal epithelial differentiation: New insights from chimeric and transgenic mice
33. The differentiation and lineage development of goblet cells in the murine small intestinal crypt: Experimental and modelling studies
34. Clonal analysis of mouse intestinal epithelial progenitors
35. Cell migration pathway in the intestinal epithelium: An in situ marker system using mouse aggregation chimeras
36. Notes from some crypt watchers: Regulation of renewal in the mouse intestinal epithelium
37. A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells
38. Glucagon gene 5′-flanking sequences direct expression of simian virus 40 large T antigen to the intestine, producing carcinoma of the large bowel in transgenic mice
39. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
40. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype
41. Significance of spontaneous apoptosis during colorectal tumorigenesis
42. Detection of apoptotic cells in human colorectal cancer by two different in situ methods: Antibody against single-stranded DNA and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) methods
43. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: Apoptotic index as a biomarker in colon cancer chemoprevention and promotion
44. min and an activated ras mutation is sufficient to induce colon carcinomas
45. Short-chain fatty acid metabolism, apoptosis, and Apc-initiated tumorigenesis in the mouse gastrointestinal mucosa
46. Stalking the guardian of the genome: P53 in colorectal carcinogenesis
47. Molecular controls of growth arrest and apoptosis: P53-dependent and -independent pathways